Djaldetti R - Search Results

1

CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.

Herman S, Djaldetti R, Mollenhauer B, Offen D. Herman S, et al. Among authors: djaldetti r. Brain. 2023 Jan 5;146(1):209-224. doi: 10.1093/brain/awac261. Brain. 2023. PMID: 35881523

2

Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers.

Achiron A, Pinhas-Hamiel O, Barak Y, Doll L, Offen D, Djaldetti R, Frankel G, Shohat B. Achiron A, et al. Among authors: djaldetti r. Arch Virol. 1996;141(1):147-53. doi: 10.1007/BF01718595. Arch Virol. 1996. PMID: 8629942

3

Gastric emptying in Parkinson's disease: patients with and without response fluctuations.

Djaldetti R, Baron J, Ziv I, Melamed E. Djaldetti R, et al. Neurology. 1996 Apr;46(4):1051-4. doi: 10.1212/wnl.46.4.1051. Neurology. 1996. PMID: 8780089

4

Levodopa toxicity and apoptosis.

Melamed E, Offen D, Shirvan A, Djaldetti R, Barzilai A, Ziv I. Melamed E, et al. Among authors: djaldetti r. Ann Neurol. 1998 Sep;44(3 Suppl 1):S149-54. doi: 10.1002/ana.410440722. Ann Neurol. 1998. PMID: 9749587 Review.

5

Enhanced fatigue during motor performance in patients with Parkinson's disease.

Ziv I, Avraham M, Michaelov Y, Djaldetti R, Dressler R, Zoldan J, Melamed E. Ziv I, et al. Among authors: djaldetti r. Neurology. 1998 Dec;51(6):1583-6. doi: 10.1212/wnl.51.6.1583. Neurology. 1998. PMID: 9855505

6

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S. Vila M, et al. Among authors: djaldetti r. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2837-42. doi: 10.1073/pnas.051633998. Epub 2001 Feb 13. Proc Natl Acad Sci U S A. 2001. PMID: 11226327 Free PMC article.

7

New therapies for Parkinson's disease.

Djaldetti R, Melamed E. Djaldetti R, et al. J Neurol. 2001 May;248(5):357-62. doi: 10.1007/s004150170174. J Neurol. 2001. PMID: 11437155 Review.

8

Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's disease.

Gilgun-Sherki Y, Djaldetti R, Melamed E, Offen D. Gilgun-Sherki Y, et al. Among authors: djaldetti r. Pharmacogenomics J. 2004;4(5):291-306. doi: 10.1038/sj.tpj.6500260. Pharmacogenomics J. 2004. PMID: 15224083 Review.

9

Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.

Sadan O, Shemesh N, Barzilay R, Dadon-Nahum M, Blumenfeld-Katzir T, Assaf Y, Yeshurun M, Djaldetti R, Cohen Y, Melamed E, Offen D. Sadan O, et al. Among authors: djaldetti r. Exp Neurol. 2012 Apr;234(2):417-27. doi: 10.1016/j.expneurol.2011.12.045. Epub 2012 Jan 20. Exp Neurol. 2012. PMID: 22285250

10

Progression of postural changes in Parkinson's disease: quantitative assessment.

Khlebtovsky A, Djaldetti R, Rodity Y, Keret O, Tsvetov G, Slutzcki-Shraga I, Benninger F. Khlebtovsky A, et al. Among authors: djaldetti r. J Neurol. 2017 Apr;264(4):675-683. doi: 10.1007/s00415-017-8402-6. Epub 2017 Feb 2. J Neurol. 2017. PMID: 28154973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters